Biogen BIIB Cash Flow Statement (2009-2026)

NASDAQ BIIB
$253.84 +12.86 (+5.34%)
At close: Oct 22, 2026 · 4:00 PM EDT
Reported Financials

Biogen Quarterly Cash Flow Statement

Periods 70 quarters
Latest Jun 2026

Biogen reported cash from operations of $448.90M and free cash flow of $408.00M for the quarter ended Jun 2026, up 179.0% year over year. This cash flow statement covers 70 quarters of results from Mar 2009 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Mar2009 Jun2009 Sep2009 Dec2009 Mar2010 Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
329.20M-20.50M303.80M1,058.70M1,134.90M550.40M387.90M593.30M-68.30M248.90M393.40M583.60M388.50M266.70M240.50M634.80M466.50M-48.90M319.50M97.50M
Depreciation and DepletionDep. & Depletion
65.10M66.60M76.30M67.20M64.20M64.70M62.10M64.50M64.10M63.50M69.30M71.90M72.70M72.80M71.40M66.90M66.50M68.00M67.90M67.90M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
133.20M134.70M143.10M134.80M120.70M119.80M112.30M117.40M125.00M140.10M147.50M158.90M182.80M184.00M183.20M194.30M202.20M200.20M204.40M236.10M
Share-based CompensationStock Comp.
55.70M58.80M67.60M55.70M63.60M67.20M75.60M71.50M62.20M54.90M72.80M70.60M72.70M75.10M81.00M74.90M75.30M59.60M84.00M77.40M
Deferred Taxes
-127.30M323.30M1.00M-48.50M-92.30M-28.80M-64.50M-106.40M-206.80M71.90M39.90M-87.00M-52.60M-58.40M-27.80M-31.30M253.80M166.90M23.60M-27.60M
Gains from Equity InvestmentsGains Equity
1.10M17.70M-3.30M5.90M
Gains from Sales and DivestituresGains Divest
Gains from Investment SecuritiesGains Investment
-426.90M-116.30M-191.10M1,696.50M-79.60M106.40M-302.50M-1.40M-31.30M-30.30M38.90M-78.70M-40.90M7.70M-0.50M14.40M19.00M42.80M
Asset Writedowns and ImpairmentWritedown
43.40M281.50M24.10M16.00M14.60M17.40M19.40M62.30M27.50M20.20M33.20M7.30M3.50M39.00M4.80M
Other non-cash itemsOther Non-Cash
19.70M43.30M60.40M31.40M29.10M81.10M69.50M23.80M85.60M67.70M13.20M5.60M151.00M156.10M2.50M
Change in Working Capital
Change in ReceivablesChange Receivables
53.70M-167.00M87.50M-20.20M42.20M93.90M-77.20M62.10M88.50M-134.70M-84.40M87.20M-114.50M-110.60M110.60M55.70M-229.40M-39.60M-69.70M223.90M
Change in InventoryChange Inventory
128.80M139.80M142.60M100.70M95.00M-18.10M-27.90M93.00M-30.20M96.00M77.70M110.50M19.20M66.40M-62.00M89.90M7.40M29.40M-116.20M-75.70M
Change in Accured ExpensesChange Accured Exp.
-54.90M147.90M-461.60M1,095.60M-1.70M-745.70M-295.00M167.90M421.00M-495.50M-177.10M61.50M31.40M108.80M-300.50M-18.20M286.00M203.80M-243.20M-49.70M
Change in TaxesChange Taxes
89.00M-29.70M101.90M-167.80M-34.30M-42.10M65.00M-147.40M-32.40M-184.20M-2.20M-5.50M69.80M16.40M69.10M-603.80M-229.40M-194.00M18.40M13.80M
Change in Other Operating AssetsOther Assets Change
-22.20M-22.90M46.50M-20.60M-37.60M
Change in Other Operating LiabilitiesOther Liabilities Change
Other Working Capital ChangesOther WC Changes
9.70M88.80M-213.60M79.60M149.90M-34.90M-96.80M41.30M-15.90M66.80M-56.10M-46.90M37.30M37.60M-53.50M-22.00M-104.40M119.30M-89.00M-54.00M
Cash from OperationsCash from Ops.
805.30M838.30M161.80M736.50M661.00M-175.00M455.30M487.00M592.40M12.50M553.20M625.80M935.60M760.90M259.30M160.90M1,272.50M511.90M645.50M448.90M
Investing Activities
Capital ExpendituresCapex
42.00M51.60M57.90M36.90M59.10M86.40M66.60M71.00M74.20M65.20M45.90M33.50M35.00M39.30M37.10M26.60M46.20M43.90M51.20M40.90M
Sales of Property, Plant and EquipmentPP&E (Sale)
-28.10M28.10M-582.60M-14.40M
Change in Property, Plant and EquipmentChange in PP&E
-70.10M-23.50M-57.90M-36.90M-59.10M-669.00M-66.60M-71.00M-74.20M-65.20M-45.90M-33.50M-49.40M-39.30M-37.10M-26.60M-46.20M-43.90M-51.20M-40.90M
Change in IntangiblesChange Intangibless
18.00M0.80M1.90M1.00M5.00M16.00M13.40M75.00M9.10M95.00M27.00M10.00M5.30M34.70M35.00M100.00M
Acquisitions
590.50M
Divestments
-28.10M990.30M
Net of Acquisitions & DivestmentsNet Acquisitions
-28.10M990.30M-590.50M
Purchase of InvestmentsInvestments Purchased
745.70M1,436.10M1,133.50M1,178.10M494.30M642.60M1,321.20M2,799.10M1,020.40M91.00M1,167.30M748.80M147.80M
Sale and Maturity of InvestmentsInvestments Sold
575.40M-2,025.80M543.60M1,908.20M1,643.20M-4,095.00M440.50M2,133.00M5,701.60M-8,155.50M55.60M408.70M39.20M-358.80M56.60M0.10M625.70M1,515.20M
Other Investing ActivitiesOther investing
-1.40M12.30M-0.20M2.20M-0.20M22.60M-0.70M-0.40M-0.20M-10.00M-0.70M-2.60M-1.10M-0.30M-0.20M-30.40M50.80M22.70M-0.20M-0.60M
Cash from Investing ActivitiesCash from Investing
-233.60M-112.70M-648.00M693.50M1,672.20M-141.10M-953.00M-753.50M-1,742.20M-652.30M-66.00M466.50M-1,181.10M-18.60M-47.30M-57.00M-35.10M-1,231.70M-209.50M-3,839.20M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
-0.30M
Long-Term Debt RepaymentsLT Debt Repayment
-170.00M1,002.20M-1,002.20M159.90M650.00M400.00M250.00M1,750.00M
Non-Current Debt
170.00M-1,002.20M1,002.20M-159.90M-650.00M-400.00M-250.00M-1,750.00M-0.30M
Short-Term Debt repaymentsST Debt Repayment
Current Debt
Net Debt Issuances and RepaymentsNet Debt Issuance
170.00M-1,002.20M1,002.20M-159.90M-650.00M-400.00M-250.00M-1,750.00M-0.30M
Change in Capital Stock
Common Stock IssuedStock Issued
Shares Repurchased
750.00M500.00M250.00M
Net Shares Issued and RepurchasedNet Shares Issued
-750.00M-500.00M-250.00M
Net Equity Issued and RepurchasedNet Equity Issued
-750.00M-500.00M-250.00M
Dividend Payments
Dividends Paid - CommonDiv. Paid (Common)
Dividends Paid - Common and PrefferdDiv Paid (Total)
Other financing activitiesOther financing
3.50M9.80M-16.50M28.50M0.30M-7.40M-43.40M-9.80M11.30M3.90M-39.60M4.80M-6.60M7.90M-23.00M4.90M-129.90M-137.00M-43.80M-7.30M
Cash from Financing ActivitiesCash from Financing
-746.50M9.80M-16.50M-471.50M-1,251.90M-7.40M-43.40M-9.80M848.60M-646.10M-439.60M-245.20M-6.60M7.90M-23.00M-11.70M-130.20M-137.00M-43.80M1,296.00M
Additional items
Exchange Rate EffectFX Effect
-25.40M-15.80M-9.40M-61.20M-52.30M67.20M20.00M-4.10M-28.70M47.90M-23.10M-12.60M42.40M-74.40M34.30M68.30M-3.20M2.50M-18.00M-3.40M
Change in Cash
-174.80M735.40M-502.70M958.50M1,081.30M-323.50M-541.10M-276.30M-301.20M-1,285.90M47.60M847.10M-252.10M750.20M189.00M92.20M1,107.20M-856.80M392.20M-2,094.30M
Ending Cash Balance
1,541.80M2,261.40M1,749.30M2,646.60M3,675.60M3,419.30M2,898.20M2,617.80M2,287.90M1,049.90M1,074.40M1,908.90M1,699.20M2,375.00M2,598.30M2,758.80M3,862.80M3,008.50M3,382.70M1,285.00M
Free Cash FlowFCF
763.30M786.70M103.90M699.60M601.90M-261.40M388.70M416.00M518.20M-52.70M507.30M592.30M900.60M721.60M222.20M134.30M1,226.30M468.00M594.30M408.00M
Net Cash FlowNCF
-174.80M735.40M-502.70M958.50M1,081.30M-323.50M-541.10M-276.30M-301.20M-1,285.90M47.60M847.10M-252.10M750.20M189.00M92.20M1,107.20M-856.80M392.20M-2,094.30M

Biogen Cash Flow Statement API

Pull Biogen's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=BIIB&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY